BBLG - Bone Biologics Corp

0.7395
0.020   2.637%

Share volume: 60,316
Last Updated: 04-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$0.72
0.02
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
17%
Profitability 0%
Dept financing 5%
Liquidity 50%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-14.01%
1 Month
-9.51%
3 Months
-26.78%
6 Months
-58.46%
1 Year
-58.46%
2 Year
-64.60%
Key data
Stock price
$0.74
P/E Ratio 
0.00
DAY RANGE
$0.64 - $0.74
EPS 
-$7.91
52 WEEK RANGE
$0.64 - $4.25
52 WEEK CHANGE
-$56.50
MARKET CAP 
7.930 M
YIELD 
N/A
SHARES OUTSTANDING 
1.801 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$103,977
AVERAGE 30 VOLUME 
$53,582
Company detail
CEO: Jeffrey Frelick
Region: US
Website: bonebiologics.com
Employees: 2
IPO year: 2025
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

Recent news
loading